Ontario Teachers Pension Plan Board Takes $3.68 Million Position in Avantor, Inc. $AVTR

Ontario Teachers Pension Plan Board bought a new position in shares of Avantor, Inc. (NYSE:AVTR) in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 294,746 shares of the company’s stock, valued at approximately $3,678,000.

Several other hedge funds have also added to or reduced their stakes in AVTR. Dodge & Cox increased its position in Avantor by 17.1% in the second quarter. Dodge & Cox now owns 117,433,484 shares of the company’s stock worth $1,580,655,000 after purchasing an additional 17,170,761 shares during the period. Vanguard Group Inc. boosted its stake in shares of Avantor by 1.8% in the 3rd quarter. Vanguard Group Inc. now owns 65,988,977 shares of the company’s stock valued at $823,542,000 after purchasing an additional 1,135,279 shares during the last quarter. Greenhaven Associates Inc. acquired a new stake in shares of Avantor during the 3rd quarter worth approximately $228,528,000. Invesco Ltd. raised its stake in shares of Avantor by 36.5% during the second quarter. Invesco Ltd. now owns 15,933,860 shares of the company’s stock worth $214,470,000 after buying an additional 4,264,449 shares during the last quarter. Finally, The Manufacturers Life Insurance Company lifted its holdings in Avantor by 13.4% in the second quarter. The Manufacturers Life Insurance Company now owns 15,914,573 shares of the company’s stock valued at $214,210,000 after buying an additional 1,879,874 shares during the period. Institutional investors own 95.08% of the company’s stock.

Avantor Stock Performance

Shares of AVTR stock opened at $9.28 on Thursday. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.18 and a current ratio of 1.78. Avantor, Inc. has a 52 week low of $8.90 and a 52 week high of $18.02. The company’s 50 day moving average price is $11.27 and its two-hundred day moving average price is $12.13. The company has a market capitalization of $6.33 billion, a P/E ratio of -11.90, a price-to-earnings-growth ratio of 3.56 and a beta of 0.94.

Avantor (NYSE:AVTR) last issued its quarterly earnings data on Wednesday, February 11th. The company reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.21 by $0.01. Avantor had a negative net margin of 8.09% and a positive return on equity of 10.45%. The company had revenue of $1.66 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the prior year, the firm earned $0.27 earnings per share. The firm’s revenue was down 1.4% compared to the same quarter last year. Avantor has set its FY 2026 guidance at 0.770-0.830 EPS. On average, analysts expect that Avantor, Inc. will post 1.06 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Gregory L. Summe acquired 100,000 shares of Avantor stock in a transaction dated Thursday, February 12th. The stock was bought at an average cost of $9.40 per share, with a total value of $940,000.00. Following the completion of the transaction, the director directly owned 400,000 shares of the company’s stock, valued at approximately $3,760,000. This represents a 33.33% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Sanjeev K. Mehra bought 350,000 shares of the company’s stock in a transaction that occurred on Friday, December 5th. The stock was purchased at an average cost of $11.09 per share, for a total transaction of $3,881,500.00. Following the transaction, the director owned 350,000 shares in the company, valued at $3,881,500. The trade was a ∞ increase in their position. The SEC filing for this purchase provides additional information. Company insiders own 1.20% of the company’s stock.

Analyst Upgrades and Downgrades

AVTR has been the subject of a number of analyst reports. Evercore set a $10.00 target price on shares of Avantor in a report on Wednesday, February 11th. JPMorgan Chase & Co. restated a “neutral” rating and issued a $12.00 price target (down from $14.00) on shares of Avantor in a research report on Thursday, October 30th. Barclays dropped their price objective on Avantor from $12.00 to $9.00 and set an “equal weight” rating for the company in a report on Thursday, February 12th. TD Cowen reissued a “hold” rating on shares of Avantor in a research note on Thursday, February 12th. Finally, Raymond James Financial lowered Avantor from an “outperform” rating to a “market perform” rating in a research report on Tuesday, November 4th. Three equities research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Avantor currently has a consensus rating of “Hold” and a consensus price target of $11.83.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.